To continue or not to continue? antipsychotic medication maintenance versus dose-reduction/discontinuation in first episode psychosis: hamlett, a pragmatic multicenter single-blind randomized controlled trial

HIGHLIGHTS

• who: Marieke J. H. Begemann from the Department of Biomedical Sciences of Cells and Systems, Cognitive Neurosciences, University of Groningen, University Medical Center Groningen (UMCG), Groningen, The Netherlands have published the paper: To continue or not to continue? Antipsychotic medication maintenance versus dose-reduction/discontinuation in first episode psychosis: HAMLETT, a pragmatic multicenter single-blind randomized controlled trial, in the Journal: (JOURNAL) of 23/06/2003
• what: The aim of the HAMLETT study is to investigate whether long-term (i.e., 4 years) functional and symptomatic recovery of patients remitted from a FEP is improved . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.